Standard Operating Procedure for Incorporation of Solubility Enhancers in Lyophilized Products
1) Purpose
This SOP outlines the procedure for incorporating solubility enhancers into lyophilized products to improve the solubility of poorly soluble drugs upon reconstitution.
2) Scope
This SOP applies to all personnel involved in the preparation of lyophilized products requiring solubility enhancers, including formulation scientists, production operators, and QA personnel.
3) Responsibilities
- Formulation Scientists: Responsible for selecting solubility enhancers based on the solubility requirements of the drug.
- Operators: Responsible for incorporating solubility enhancers as outlined in the Batch Manufacturing Record (BMR).
- QA: Responsible for verifying the incorporation of solubility enhancers and ensuring proper documentation.
4) Procedure
4.1 Selection of Solubility Enhancers
4.1.1 Criteria for Selection
- 4.1.1.1 Solubility enhancers must improve the dissolution rate of the active ingredient without affecting its stability. Common enhancers include cyclodextrins, surfactants, and hydrotropes.
4.2 Incorporation of Solubility Enhancers
4.2.1 Weighing and Dispensing
- 4.2.1.1 Weigh the solubility enhancers using a calibrated balance as specified in the BMR.
- 4.2.1.2 Add the enhancers to the formulation solution while stirring to ensure even distribution.
4.2.2 Mixing and Homogenization
- 4.2.2.1 Stir the solution using a mechanical stirrer to ensure uniform distribution of the solubility enhancers.
- 4.2.2.2 Homogenize the mixture if necessary to ensure uniformity.
4.3 Filtration and Filling
- 4.3.1 Filter the solution using a sterile 0.22-micron filter and fill into vials as per the BMR for lyophilization.
4.4 Documentation
Record all steps, including the addition of solubility enhancers, filtration, and lyophilization parameters, in the Solubility Enhancer Incorporation Logbook and ensure QA verification.
5) Abbreviations
- BMR: Batch Manufacturing Record
6) Documents
- Solubility Enhancer Incorporation Logbook
7) References
- Pharmacopoeial guidelines for the use of solubility enhancers in lyophilized formulations
8) SOP Version
Version 1.0
Annexure
Solubility Enhancer Incorporation Logbook Template
Date | Solubility Enhancer | Batch No. | Quantity | Operator Initials | QA Verification |
---|---|---|---|---|---|
DD/MM/YYYY | Solubility Enhancer | Batch Number | Quantity (grams) | Operator Name | QA Initials |